IL1-TRAP, Rilonacept, in Systemic Sclerosis

NCT01538719 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Scleroderma
Systemic Sclerosis
Diffuse Scleroderma
Diffuse Systemic Sclerosis

Interventions

DRUG: Rilonacept
OTHER: Placebo

Sponsor

Boston University

Collaborators

[object Object]